{"count":1,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/d1ff1c25-c9e6-4ac0-86e6-d5b89f05dc91/","filing_uuid":"d1ff1c25-c9e6-4ac0-86e6-d5b89f05dc91","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d1ff1c25-c9e6-4ac0-86e6-d5b89f05dc91/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Karin Ross","dt_posted":"2026-10-20T12:38:15-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"555 13TH ST NW","registrant_address_2":"SUITE 300W","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":10935,"url":"https://lda.gov/api/v1/registrants/10935/","house_registrant_id":31823,"name":"THE PERSONAL CARE PRODUCTS COUNCIL","description":null,"address_1":"555 13TH ST NW","address_2":"SUITE 300W","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"EMILY MANOSO","contact_telephone":"+1 202-351-1739","dt_updated":"2026-07-30T10:36:36.641431-04:00"},"client":{"id":114903,"url":"https://lda.gov/api/v1/clients/114903/","client_id":12,"name":"PERSONAL CARE PRODUCTS COUNCIL","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-03"},"lobbying_activities":[{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"HR 2269/S 1092, WIPPES Act (product labeling for non-flushable wipes); H.R. 2853 / S. 1404,Combating Organized Retail Crime Act; H.R. 4433, Toxic-Free Beauty Act; H.R. 9594 No PFAS In Cosmetics Act; H.R. 6832, Packaging and Claims Knowledge (PACK) Act of 2025; H.R. 7205Recycled Materials Attributions Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":121069,"prefix":null,"prefix_display":null,"first_name":"KARIN","nickname":null,"middle_name":null,"last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149583,"prefix":null,"prefix_display":null,"first_name":"GENEVIEVE","nickname":null,"middle_name":null,"last_name":"STRAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ANI","general_issue_code_display":"Animals","description":"HR 1657, Humane Cosmetics Act; H.R. 2821/S. 355, FDA Modernization Act 3.0 (issues related to animal-based testing for OTC products); Adoption of non-animal test methods/New Approach Methodologies (NAMs)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":121069,"prefix":null,"prefix_display":null,"first_name":"KARIN","nickname":null,"middle_name":null,"last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149583,"prefix":null,"prefix_display":null,"first_name":"GENEVIEVE","nickname":null,"middle_name":null,"last_name":"STRAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142328,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"BAILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (cosmetic regulation funding issues); Fiscal Year 2027 Appropriations package (funding for the Department of Defense's Melanoma Research Program).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":121069,"prefix":null,"prefix_display":null,"first_name":"KARIN","nickname":null,"middle_name":null,"last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149583,"prefix":null,"prefix_display":null,"first_name":"GENEVIEVE","nickname":null,"middle_name":null,"last_name":"STRAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142328,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"BAILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Over-the-Counter Monograph User Fees (issues related to the OMUFA program); Implementation of provision from the Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":121069,"prefix":null,"prefix_display":null,"first_name":"KARIN","nickname":null,"middle_name":null,"last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149583,"prefix":null,"prefix_display":null,"first_name":"GENEVIEVE","nickname":null,"middle_name":null,"last_name":"STRAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142328,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"BAILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Section 301, Section 232 and IEEPA Tariffs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":121069,"prefix":null,"prefix_display":null,"first_name":"KARIN","nickname":null,"middle_name":null,"last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69385,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"OBERMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149583,"prefix":null,"prefix_display":null,"first_name":"GENEVIEVE","nickname":null,"middle_name":null,"last_name":"STRAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"SHOP SAFE Act (issues related to counterfeit cosmetic products); H.R. 4390: To expand the sharing of information with respect to suspected violations of intellectual property rights in trade (issues related to counterfeit cosmetic products).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149583,"prefix":null,"prefix_display":null,"first_name":"GENEVIEVE","nickname":null,"middle_name":null,"last_name":"STRAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":121069,"prefix":null,"prefix_display":null,"first_name":"KARIN","nickname":null,"middle_name":null,"last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"US Mexico Canada Agreement Review; Trade issues with China.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149583,"prefix":null,"prefix_display":null,"first_name":"GENEVIEVE","nickname":null,"middle_name":null,"last_name":"STRAND","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":121069,"prefix":null,"prefix_display":null,"first_name":"KARIN","nickname":null,"middle_name":null,"last_name":"ROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69385,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"OBERMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}